| Description | Atrasentan, also known as ABT-627, is a orally available ETA receptor antagonist with potential antineoplastic activity. As a selective antagonist of the endothelin-A (ETA) receptor, atrasentan binds selectively to the ETA receptor, which may result in inhibition of endothelin-induced angiogenesis and tumor cell proliferation. |
| molecular weight | 532.61 |
| Molecular formula | C29H37N2NaO6 |
| CAS | 178738-96-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |